[Procurement of Inj.Sacituzamab Govitecan-200 Mg] open

Overview

The All India Institute of Medical Science-New Delhi is inviting bids for the procurement of Inj.Sacituzamab Govitecan-200 Mg under the tender ID 2026_AIMSD_908440_1. This is a global tender aimed at acquiring pharmaceutical products, specifically drugs, with a total tender value of ₹20,00,000. The tender was published on 12-May-2026 and is open for submissions until 02-Jun-2026.

Scope / Work

The primary objective of this tender is to procure Inj.Sacituzamab Govitecan-200 Mg. Bidders are required to refer to the tender documents for specific pre-qualification criteria and other detailed requirements. The contract will be awarded based on the evaluation of bids submitted in two covers: one for technical and fee documents, and the other for the financial bid. The period of work is expected to last for 45 days from the date of contract award.

Fees & EMD

There is no tender fee associated with this procurement. However, an Earnest Money Deposit (EMD) of ₹40,000 is required, which must be submitted to the Chief, Dr.BRAIRCH at AIIMS New Delhi. Bidders should note that EMD exemption is allowed, and the payment can be made through various offline instruments, including Demand Draft, FDR, Bankers Cheque, or Bank Guarantee.

Key dates

• Tender Publish Date: 12-May-2026 06:45 PM
• Bid Submission Start Date: 12-May-2026 06:45 PM
• Bid Submission End Date: 02-Jun-2026 05:00 PM
• Bid Opening Date: 03-Jun-2026 05:00 PM
• Document Download Start Date: 12-May-2026 06:45 PM
• Document Download End Date: 02-Jun-2026 05:00 PM

Bidders are encouraged to download the tender documents promptly and ensure all submissions are made before the deadline to avoid disqualification.